| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $222.2M | — | +6.2% |
| Cost of Revenue | $13.6M | — | -25.3% |
| R&D Expense | $16.8M | — | +0.0% |
| SG&A Expense | $15.5M | — | +12.3% |
| Operating Income | $27.2M | — | +3785.7% |
| Pre-tax Income | $28.0M | — | +2053.8% |
| Income Tax | $7.6M | — | +590.9% |
| Net Income | $20.4M | — | — |
| EPS (Basic) | $0.30 | — | — |
| EPS (Diluted) | $0.29 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.3M | -42.7% | -38.9% |
| Accounts Receivable | $113.1M | +1.9% | -6.0% |
| Current Assets | $206.4M | -15.7% | -14.7% |
| Total Assets | $432.0M | -6.3% | -9.1% |
| Current Liabilities | $80.3M | +13.3% | -11.2% |
| Total Liabilities | $95.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $35.7M | — | +33.7% |
| Capital Expenditures | $400K | — | +100.0% |
| Investing Cash Flow | -$19.7M | — | -328.3% |
| Financing Cash Flow | -$57.9M | — | -1623.7% |
| Free Cash Flow | $35.3M | — | +33.2% |
| -7.4% |
| Stockholders' Equity | $336.2M | -10.2% | -9.5% |